Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ProKidney Corp. (PROK)
USD1.59
+0.04 (+2.58%)
US NASDAQ Healthcare Biotechnology
Address
2000 Frontis Plaza Blvd. 27103
Winston-Salem, NC, US
Winston-Salem, NC, US
CEO
Bruce Culleton
Website
prokidney.com
IPO
2021-06-30
CIK 1850270 ISIN US74291D1046
Also trades on
NASDAQ Capital Market · DNAC (USD)
NASDAQ Capital Market · PROK (USD)
Description
ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments. Their flagship product is Renal Autologous Cell Therapy (RAC-T), a unique cellular admixture derived from a patient's own cells. RAC-T is undergoing significant clinical evaluation; it is concurrently in Phase III and Phase II trials for individuals with moderate to severe diabetic kidney disease. Furthermore, the company is conducting a Phase I clinical trial to assess RAC-T's potential for patients born with congenital anomalies affecting the kidneys and urinary tract. The company was established in 2015 and operates from its headquarters in Winston-Salem, North Carolina.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.59
+0.04 (+2.58%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.70
Float Shares
93.69M
Free Float %
73.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.92% | -11.70% | -23.85% | -17.82% | -26.22% | -25.89% | +105.34% | -83.71% | -83.58% | -83.58% | -83.58% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
1.59
Low
3.00
+88.7%
Consensus
4.67
+193.7%
Median
5.00
+214.5%
High
6.00
+277.4%
DCF (Unlevered)
0.88
-44.5%
DCF (Levered)
0.76
-52.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
57% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 5 |
7.00
+340.3%
|
Quality scores
Altman Z-Score
3.68
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+1,075.0% ★ Q1'26: -1.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+16.1% Q1'26: -7.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-18,345.6% Q1'26: -18,444.2% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-18,442.2% Q1'26: -19,881.9% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-488.1% Q1'26: -8.1% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+36.8% Q1'26: +109,939.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
76.0K
est: 306.0K (-75.2%)
|
893.0K
est: 543.4K (+64.3%)
|
341.3K
276.8K – 406.3K
-37.2% YoY
|
299.2K
242.6K – 356.2K
-12.4% YoY
|
57.99M
47.02M – 69.04M
+19,284.1% YoY
|
128.60M
104.28M – 153.10M
+121.8% YoY
|
333.82M
270.67M – 397.40M
+159.6% YoY
|
| EBITDA |
-158.49M
est: 61.2K (-259,078.1%)
|
-158.97M
est: 108.7K (-146,364.0%)
|
68.3K
55.4K – 81.3K
-37.2% YoY
|
59.8K
48.5K – 71.2K
-12.4% YoY
|
11.60M
9.40M – 13.81M
+19,284.3% YoY
|
25.72M
20.86M – 30.62M
+121.8% YoY
|
66.76M
54.13M – 79.48M
+159.6% YoY
|
| EBIT |
-163.92M
est: 61.2K (-267,954.0%)
|
-164.69M
est: 108.7K (-151,628.7%)
|
68.3K
55.4K – 81.3K
-37.2% YoY
|
59.8K
48.5K – 71.2K
-12.4% YoY
|
11.60M
9.40M – 13.81M
+19,284.3% YoY
|
25.72M
20.86M – 30.62M
+121.8% YoY
|
66.76M
54.13M – 79.48M
+159.6% YoY
|
| Net Income |
-61.19M
est: -78.05M (+21.6%)
|
-68.99M
est: -68.99M (+0.0%)
|
-89.20M
-165.23M – -63.55M
-29.3% YoY
|
-110.58M
-171.46M – -53.74M
-24.0% YoY
|
-53.84M
-65.30M – -42.38M
+51.3% YoY
|
-34.83M
-43.45M – -26.26M
+35.3% YoY
|
15.63M
11.78M – 19.50M
+144.9% YoY
|
| SGA |
56.08M
est: 48.89M (+14.7%)
|
51.78M
est: 86.83M (-40.4%)
|
54.54M
44.22M – 64.93M
-37.2% YoY
|
47.80M
38.76M – 56.91M
-12.4% YoY
|
9.27B
7.51B – 11.03B
+19,284.1% YoY
|
20.55B
16.66B – 24.46B
+121.8% YoY
|
53.34B
43.25B – 63.50B
+159.6% YoY
|
| EPS |
-0.62
est: -0.58 (-6.4%)
|
-0.52
est: -0.58 (+9.6%)
|
-0.68
-1.23 – -0.47
-18.8% YoY
|
-0.70
-1.28 – -0.40
-2.1% YoY
|
-0.39
-0.49 – -0.32
+44.0% YoY
|
-0.26
-0.32 – -0.20
+33.4% YoY
|
0.12
0.09 – 0.15
+144.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-22.28M
OE per share TTM
-0.17
Owner's Yield
-4.11%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
19,190.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
12
Total invested
4.22M
Insider transactions (90d)
1
Beneficial owners (>5%)
45
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pablo Legorreta | 94.68M | 40.80% | — | 94.68M | — | 94.68M | IN | — | 2022-07-22 | ↗ |
| 2 | Tolerantia, LLC | 94.68M | 40.80% | — | 94.68M | — | 94.68M | OO | — | 2022-07-22 | ↗ |
| 3 | Carlos Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 4 | Carlos Slim Helu | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 5 | Control Empresarial de Capitales, S.A. de C.V. | 63.12M | 27.20% | — | 63.12M | — | 63.12M | HC | — | 2022-07-22 | ↗ |
| 6 | Johanna Monique Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 7 | Marco Antonio Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 8 | Maria Soumaya Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 9 | Patrick Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 10 | Vanessa Paola Slim Domit | 63.12M | 27.20% | — | 63.12M | — | 63.12M | IN | — | 2022-07-22 | ↗ |
| 11 | Chamath Palihapitiya | 16.27M | 26.40% | — | 16.27M | — | 16.27M | IN | United States | 2022-07-20 | ↗ |
| 12 | SC Master Holdings, LLC | 13.27M | 21.60% | — | 13.27M | — | 13.27M | OO | United States | 2022-07-20 | ↗ |
| 13 | Morgan Stanley | 10.00M | 16.20% | — | — | 9.99M | 10.00M | HC, CO | Delaware. | 2022-09-12 | ↗ |
| 14 | Morgan Stanley Investment Management Inc. | 10.00M | 16.20% | — | — | — | 10.00M | IA, CO | Delaware. | 2022-09-12 | ↗ |
| 15 | SC PIPE Holdings LLC | 9.50M | 15.40% | — | 9.50M | — | 9.50M | OO | United States | 2022-07-20 | ↗ |
| 16 | SC SPAC Holdings LLC | 6.86M | 21.50% | — | 6.86M | — | 6.86M | OO | — | 2022-02-09 | ↗ |
| 17 | SCS Sponsor III LLC | 6.86M | 21.50% | — | 6.86M | — | 6.86M | OO | — | 2022-02-09 | ↗ |
| 18 | Aaron Cowen | 6.27M | 10.20% | — | 6.27M | — | — | IN | Delaware | 2022-07-22 | ↗ |
| 19 | Morgan Stanley Institutional Fund, Inc. - Growth Portfolio | 3.87M | 6.20% | — | 3.87M | — | 3.87M | IV | Delaware. | 2022-09-12 | ↗ |
| 20 | Averill Master Fund, Ltd. | 3.18M | 5.20% | — | 3.18M | — | — | CO | Delaware | 2022-07-22 | ↗ |
| 21 | Suvretta Capital Management, LLC | 3.18M | 5.20% | — | 3.18M | — | — | IA, OO | Delaware | 2022-07-22 | ↗ |
| 22 | Kishan Mehta | 3.09M | 5.10% | — | 3.09M | — | — | IN | Delaware | 2022-07-22 | ↗ |
| 23 | SVAV Sponsor III, LLC | 3.09M | 5.10% | — | 3.09M | — | — | PN | Delaware | 2022-07-22 | ↗ |
| 24 | Adage Capital Advisors, L.L.C. | 1.75M | 6.83% | — | 1.75M | — | — | OO | Delaware | 2021-07-12 | ↗ |
| 25 | Adage Capital Partners GP, L.L.C. | 1.75M | 6.83% | — | 1.75M | — | — | OO | Delaware | 2021-07-12 | ↗ |
| 26 | Adage Capital Partners, L.P. | 1.75M | 6.83% | — | 1.75M | — | — | PN | Delaware | 2021-07-12 | ↗ |
| 27 | Phillip Gross | 1.75M | 6.83% | — | 1.75M | — | — | IN | Delaware | 2021-07-12 | ↗ |
| 28 | Robert Atchinson | 1.75M | 6.83% | — | 1.75M | — | — | IN | Delaware | 2021-07-12 | ↗ |
| 29 | Israel A. Englander | 1.57M | 6.10% | — | 1.57M | — | 1.57M | IN | — | 2021-07-08 | ↗ |
| 30 | Millennium Group Management LLC | 1.57M | 6.10% | — | 1.57M | — | 1.57M | OO | — | 2021-07-08 | ↗ |
| 31 | Millennium Management LLC | 1.57M | 6.10% | — | 1.57M | — | 1.57M | OO | — | 2021-07-08 | ↗ |
| 32 | Sculptor Capital Holding Corp. | 1.30M | 5.07% | — | 1.30M | — | 1.30M | CO | Delaware | 2021-12-29 | ↗ |
| 33 | Sculptor Capital Holding II LLC | 1.30M | 5.07% | — | 1.30M | — | 1.30M | CO | Delaware | 2021-12-29 | ↗ |
| 34 | Sculptor Capital II LP | 1.30M | 5.07% | — | 1.30M | — | 1.30M | IA | Delaware | 2021-12-29 | ↗ |
| 35 | Sculptor Capital LP | 1.30M | 5.07% | — | 1.30M | — | 1.30M | IA | Delaware | 2021-12-29 | ↗ |
| 36 | Sculptor Capital Management, Inc. | 1.30M | 5.07% | — | 1.30M | — | 1.30M | CO | Delaware | 2021-12-29 | ↗ |
| 37 | Integrated Core Strategies (US) LLC | 760.0K | 3.00% | — | 760.0K | — | 760.0K | OO | — | 2021-07-08 | ↗ |
| 38 | Sculptor Master Fund, Ltd. | 605.5K | 2.36% | — | 605.5K | — | 605.5K | CO | Delaware | 2021-12-29 | ↗ |
| 39 | Sculptor Special Funding, LP | 605.5K | 2.36% | — | 605.5K | — | 605.5K | CO | Delaware | 2021-12-29 | ↗ |
| 40 | Riverview Group LLC | 500.0K | 2.00% | — | 500.0K | — | 500.0K | OO | — | 2021-07-08 | ↗ |
| 41 | Sculptor SC II LP | 445.1K | 1.74% | — | 445.1K | — | 445.1K | CO | Delaware | 2021-12-29 | ↗ |
| 42 | ICS Opportunities, Ltd. | 311.2K | 1.20% | — | 311.2K | — | 311.2K | CO | — | 2021-07-08 | ↗ |
| 43 | Millennium International Management LP | 311.2K | 1.20% | — | 311.2K | — | 311.2K | PN | — | 2021-07-08 | ↗ |
| 44 | Sculptor Credit Opportunities Master Fund, Ltd. | 179.4K | 0.70% | — | 179.4K | — | 179.4K | CO | Delaware | 2021-12-29 | ↗ |
| 45 | Sculptor Enhanced Master Fund, Ltd. | 69.4K | 0.27% | — | 69.4K | — | 69.4K | CO | Delaware | 2021-12-29 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
12
-54 vs prev Q
New positions
4
Closed positions
53
Increased
6
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 12.34M +— (+0.0%) | 27.64M -2.2M (-7.4%) | 9.14% +0.000 pp | 0.57% -0.198 pp | USD2.42 -7.4% | 2 qtrs — |
| 2 | MORGAN STANLEY | 8.82M +2.1M (+30.7%) | 19.75M +3.4M (+21.0%) | 6.53% +1.533 pp | 0.00% +0.000 pp | USD2.38 -5.9% | 2 qtrs — |
| 3 | BLEICHROEDER LP | 2.00M +— (+0.0%) | 4.48M -360.0K (-7.4%) | 1.48% +0.000 pp | 0.79% -0.155 pp | USD2.42 -7.4% | 2 qtrs — |
| 4 | ARTIA GLOBAL PARTNERS LP | 1.84M +1.8M (+100.0%) | 4.12M +4.1M (+100.0%) | 1.36% +1.362 pp | 0.66% +0.657 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 5 | MILLENNIUM MANAGEMENT LLC | 1.83M -121.8K (-6.2%) | 4.11M -625.1K (-13.2%) | 1.36% -0.090 pp | 0.00% 0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 6 | VANGUARD GROUP INC | 1.65M +84.1K (+5.4%) | 3.69M -93.1K (-2.5%) | 1.22% +0.062 pp | 0.00% +0.000 pp | USD2.41 -7.1% | 2 qtrs — |
| 7 | HENNION & WALSH ASSET MANAGEMENT, INC. | 1.50M +584.0K (+63.5%) | 3.37M +1.1M (+51.3%) | 1.11% +0.433 pp | 0.12% +0.036 pp | USD2.35 -4.7% | 2 qtrs — |
| 8 | BLACKROCK, INC. | 1.40M +127.0K (+9.9%) | 3.15M +54.5K (+1.8%) | 1.04% +0.094 pp | 0.00% +0.000 pp | USD2.40 -6.7% | 2 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.20M +100.7K (+9.2%) | 2.68M +28.1K (+1.1%) | 0.89% +0.075 pp | 0.00% +0.000 pp | USD2.40 -6.7% | 2 qtrs — |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 895.7K +763.7K (+578.6%) | 2.01M +1.7M (+528.1%) | 0.66% +0.566 pp | 0.00% +0.003 pp | USD2.27 -1.3% | 2 qtrs — |
| 11 | BANK OF AMERICA CORP /DE/ | 706.1K +45.3K (+6.9%) | 1.58M -17.5K (-1.1%) | 0.52% +0.034 pp | 0.00% +0.000 pp | USD2.41 -7.1% | 2 qtrs — |
| 12 | GOLDMAN SACHS GROUP INC | 681.2K +516.5K (+313.8%) | 1.53M +1.1M (+283.0%) | 0.50% +0.383 pp | 0.00% +0.000 pp | USD2.28 -1.8% | 2 qtrs — |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 623.1K -30.0K (-4.6%) | 1.40M -184.7K (-11.7%) | 0.46% -0.022 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 14 | MARSHALL WACE, LLP | 612.5K +531.3K (+654.2%) | 1.37M +1.2M (+598.1%) | 0.45% +0.394 pp | 0.00% +0.001 pp | USD2.02 +10.9% | 3 qtrs — |
| 15 | WOODLINE PARTNERS LP | 500.0K +500.0K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.37% +0.370 pp | 0.00% +0.004 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 16 | JANE STREET GROUP, LLC | 493.8K +424.9K (+615.8%) | 1.11M +939.3K (+562.6%) | 0.37% +0.315 pp | 0.00% +0.000 pp | USD2.27 -1.3% | 2 qtrs — |
| 17 | STATE STREET CORP | 480.3K +5.4K (+1.1%) | 1.08M -73.4K (-6.4%) | 0.36% +0.004 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 18 | TWO SIGMA INVESTMENTS, LP | 465.5K +366.2K (+368.9%) | 1.04M +802.5K (+334.0%) | 0.34% +0.271 pp | 0.00% +0.001 pp | USD2.28 -1.8% | 2 qtrs — |
| 19 | MYDA ADVISORS LLC | 440.0K -10.0K (-2.2%) | 985.6K -103.4K (-9.5%) | 0.33% -0.007 pp | 0.19% -0.047 pp | USD2.42 -7.4% | 2 qtrs — |
| 20 | UBS GROUP AG | 416.5K -91.8K (-18.1%) | 933.0K -297.2K (-24.2%) | 0.31% -0.068 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 398.9K +143.9K (+56.4%) | 893.5K +276.4K (+44.8%) | 0.30% +0.107 pp | 0.00% +0.000 pp | USD2.36 -5.1% | 2 qtrs — |
| 22 | SQUAREPOINT OPS LLC | 351.4K +6.8K (+2.0%) | 787.2K -46.7K (-5.6%) | 0.26% +0.005 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 23 | AMUNDI | 272.2K +272.2K (+100.0%) | 609.8K +609.8K (+100.0%) | 0.20% +0.202 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 24 | NORTHERN TRUST CORP | 241.6K +51.5K (+27.1%) | 541.1K +81.2K (+17.7%) | 0.18% +0.038 pp | 0.00% +0.000 pp | USD2.38 -5.9% | 2 qtrs — |
| 25 | GSA CAPITAL PARTNERS LLP | 189.0K +21.0K (+12.5%) | 423.0K +16.0K (+3.9%) | 0.14% +0.016 pp | 0.04% +0.003 pp | USD2.40 -6.7% | 2 qtrs — |
| 26 | BARCLAYS PLC | 170.0K +170.0K (+17,000,000.0%) | 380.8K +380.8K (+19,040,000.0%) | 0.13% +0.126 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 2 qtrs — |
| 27 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 128.9K +23.9K (+22.8%) | 288.6K +34.7K (+13.7%) | 0.10% +0.018 pp | 0.00% 0.000 pp | USD2.39 -6.3% | 2 qtrs — |
| 28 | OMERS ADMINISTRATION CORP | 124.4K +124.4K (+100.0%) | 278.7K +278.7K (+100.0%) | 0.09% +0.092 pp | 0.00% +0.002 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 29 | VIRTUS INVESTMENT ADVISERS, INC. | 120.4K +120.4K (+100.0%) | 269.6K +269.6K (+100.0%) | 0.09% +0.089 pp | 0.07% +0.073 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 30 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 108.4K -35.0K (-24.4%) | 242.9K -104.3K (-30.0%) | 0.08% -0.026 pp | 0.00% -0.002 pp | USD2.42 -7.4% | 2 qtrs — |
| 31 | SIMPLEX TRADING, LLC | 86.0K +8.2K (+10.6%) | 192.7K +4.7K (+2.5%) | 0.06% +0.006 pp | 0.00% +0.000 pp | USD2.40 -6.7% | 2 qtrs — |
| 32 | JEFFERIES FINANCIAL GROUP INC. | 62.0K -3.3K (-5.0%) | 139.0K -19.1K (-12.1%) | 0.05% -0.002 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 33 | CITIGROUP INC | 61.7K +59.4K (+2,590.8%) | 138.3K +132.7K (+2,390.4%) | 0.05% +0.044 pp | 0.00% +0.000 pp | USD2.25 -0.4% | 2 qtrs — |
| 34 | FNY INVESTMENT ADVISERS, LLC | 59.1K +59.1K (+100.0%) | 132.0K +132.0K (+100.0%) | 0.04% +0.044 pp | 0.04% +0.037 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 35 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 48.1K +48.1K (+100.0%) | 107.7K +107.7K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.003 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 36 | CITADEL ADVISORS LLC | 47.6K -19.0K (-28.5%) | 106.6K -54.5K (-33.8%) | 0.04% -0.014 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 37 | HUDSON BAY CAPITAL MANAGEMENT LP | 45.1K +45.1K (+100.0%) | 100.9K +100.9K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 38 | ENTRYPOINT CAPITAL, LLC | 28.8K +28.8K (+100.0%) | 64.6K +64.6K (+100.0%) | 0.02% +0.021 pp | 0.03% +0.025 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 39 | GROUP ONE TRADING, L.P. | 28.0K +28.0K (+100.0%) | 62.8K +62.8K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 40 | VIRTUS FAMILY OFFICE LLC | 27.5K +— (+0.0%) | 61.6K -5.0K (-7.4%) | 0.02% +0.000 pp | 0.05% -0.009 pp | USD2.42 -7.4% | 2 qtrs — |
| 41 | POINT72 ASSET MANAGEMENT, L.P. | 17.1K +17.1K (+100.0%) | 38.3K +38.3K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 42 | LETKO, BROSSEAU & ASSOCIATES INC | 15.9K +— (+0.0%) | 35.6K -2.9K (-7.4%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 43 | CALLAN FAMILY OFFICE, LLC | 13.4K +13.4K (+100.0%) | 30.0K +30.0K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.001 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 44 | CETERA INVESTMENT ADVISERS | 12.3K +12.3K (+100.0%) | 27.5K +27.5K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 45 | VICTORY CAPITAL MANAGEMENT INC | 12.1K +715.0 (+6.3%) | 27.2K -456.0 (-1.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD2.41 -7.1% | 2 qtrs — |
| 46 | BANK OF NEW YORK MELLON CORP | 11.2K +— (+0.0%) | 25.1K -2.0K (-7.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 47 | TWO SIGMA ADVISERS, LP | 10.9K +10.9K (+100.0%) | 24.4K +24.4K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 48 | FMR LLC | 10.3K -1.6K (-13.4%) | 23.1K -5.7K (-19.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 49 | NINE MASTS CAPITAL LTD | 10.2K +10.2K (+100.0%) | 22.9K +22.9K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.004 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 50 | WELLS FARGO & COMPANY/MN | 3.0K +— (+0.0%) | 6.7K -540.0 (-7.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 51 | ROYAL BANK OF CANADA | 1.1K -146.4K (-99.3%) | 2.0K -354.0K (-99.4%) | 0.00% -0.109 pp | 0.00% 0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 52 | BNP PARIBAS ARBITRAGE, SNC | 871.00 -923.0 (-51.4%) | 2.0K -2.4K (-55.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 53 | GARNER ASSET MANAGEMENT CORP | 800.00 +800.0 (+100.0%) | 1.8K +1.8K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.001 pp | USD2.24 +0.0% | 1 qtrs NEW |
| 54 | JPMORGAN CHASE & CO | 756.00 +— (+0.0%) | 1.7K -137.0 (-7.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 55 | JONES FINANCIAL COMPANIES LLLP | 100.00 -3.2K (-97.0%) | 224.00 -8.1K (-97.3%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD2.41 -7.1% | 2 qtrs — |
| 56 | SRS CAPITAL ADVISORS, INC. | 65.00 -183.0 (-73.8%) | 146.00 -454.0 (-75.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.42 -7.4% | 2 qtrs — |
| 57 | SBI SECURITIES CO., LTD. | 50.00 +50.0 (+100.0%) | 112.00 +112.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.24 +0.0% | 3 qtrs — |
| 58 | TOWER RESEARCH CAPITAL LLC (TRC) | 15.00 -4.2K (-99.6%) | 34.00 -10.1K (-99.7%) | 0.00% -0.003 pp | 0.00% 0.000 pp | USD2.40 -6.7% | 2 qtrs — |
| 59 | ZULLO INVESTMENT GROUP, INC. | — -11.6K (-100.0%) | — -28.1K (-100.0%) | 0.00% -0.009 pp | 0.00% -0.010 pp | USD— | 2 qtrs SOLD |
| 60 | IFP ADVISORS, INC | — -9.0 (-100.0%) | — -22.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 61 | HRT FINANCIAL LP | — -211.3K (-100.0%) | — -511.0K (-100.0%) | 0.00% -0.157 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 62 | GROUPE LA FRANCAISE | — -1.5K (-100.0%) | — -3.2K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 63 | ADVISOR GROUP HOLDINGS, INC. | — -215.0 (-100.0%) | — -126.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 64 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | — -12.0 (-100.0%) | — -29.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 65 | SIGNATUREFD, LLC | — -75.0 (-100.0%) | — -182.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 14 qtrs SOLD |
| 66 | EVERSOURCE WEALTH ADVISORS, LLC | — -38.0 (-100.0%) | — -92.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 67 | ENGINEERS GATE MANAGER LP | — -10.5K (-100.0%) | — -25.3K (-100.0%) | 0.00% -0.008 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 68 | CWM, LLC | — -627.0 (-100.0%) | — -2.0K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 69 | CENTIVA CAPITAL, LP | — -90.9K (-100.0%) | — -220.0K (-100.0%) | 0.00% -0.067 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 70 | CAITLIN JOHN, LLC | — -350.0 (-100.0%) | — -847.0 (-100.0%) | 0.00% 0.000 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 71 | US BANCORP \DE\ | — -100.0 (-100.0%) | — -242.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 72 | VIRTU FINANCIAL LLC | — -84.0K (-100.0%) | — -203.0K (-100.0%) | 0.00% -0.062 pp | 0.00% -0.011 pp | USD— | 2 qtrs SOLD |
| 73 | ADVISORY SERVICES NETWORK, LLC | — -184.0 (-100.0%) | — -445.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 27 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.66% | 380.2K | 0.65% |
| 2 | iShares Micro-Cap ETF IWC | 0.03% | 446.4K | 0.60% |
| 3 | iShares Russell 2000 Growth ETF IWO | 0.00% | 718.4K | 0.24% |
| 4 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 129.8K | 0.30% |
| 5 | Global X - Russell 2000 ETF RSSL | 0.00% | 62.3K | 0.08% |
| 6 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.00% | 13.5K | 0.25% |
| 7 | Schwab U.S. Small-Cap ETF SCHA | 0.00% | 886.2K | 0.03% |
| 8 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 2.1K | 0.39% |
| 9 | iShares Russell 2000 ETF IWM | 0.00% | 3.09M | 0.19% |
| 10 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 20.2K | 0.36% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
0.50
Neutral
Buys
1
Sells
2
Shares acquired
63.12M
Shares disposed
126.24M
Cash buys
—
Cash sales
—
Net activity
-63,118,645
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | C-Conversion | A | Class A Common Shares (as defined in Exhibit 99.1 hereto) | 63,118,645 | 0.00 | — | 73,842,723 | D | ↗ |
| 2026-03-01 | Weber Darin J. | Officer | A-Award | A | Employee stock option (right to buy) | 400,000 | 2.24 | 896.0K | 400,000 | D | ↗ |
| 2026-03-01 | Girolamo Todd C | Officer | A-Award | A | Employee stock option (right to buy) | 600,000 | 2.24 | 1.34M | 600,000 | D | ↗ |
| 2026-03-01 | Culleton Bruce | Director / Officer | A-Award | A | Employee stock option (right to buy) | 3,000,000 | 2.24 | 6.72M | 3,000,000 | D | ↗ |
| 2026-03-01 | Coulston James | Officer | A-Award | A | Employee stock option (right to buy) | 600,000 | 2.24 | 1.34M | 600,000 | D | ↗ |
| 2025-11-13 | Pereira Brian JG | Director | S-Sale | D | Class A Common Stock | 54,333 | 2.37 | 128.8K | 0 | I | ↗ |
| 2025-11-12 | Pereira Brian JG | Director | S-Sale | D | Class A Common Stock | 227,431 | 2.72 | 619.4K | 447,803 | I | ↗ |
| 2025-07-11 | Cowen Aaron | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-07-08 | Weber Darin J. | Officer | S-Sale | D | Class A Common Stock | 103,480 | 3.02 | 312.5K | 0 | D | ↗ |
| 2025-06-03 | Legorreta Pablo G. | Director / 10% Owner | C-Conversion | A | Class A Ordinary Shares | 3,823,996 | 0.00 | — | 26,441,905 | I | ↗ |
| 2025-05-29 | Sinha Uma | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | Pereira Brian JG | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | Lotvin Alan | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | Legorreta Pablo G. | Director / 10% Owner | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | Jimenez Santos Jose Ignacio | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | Fox Jennifer A. | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-05-29 | DOYLE WILLIAM F | Director | A-Award | A | Director stock option (right to buy) | 125,862 | 0.72 | 90.6K | 125,862 | D | ↗ |
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 387,393 | 0.71 | 276.4K | 73,842,723 | D | ↗ |
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 25,000 | 0.75 | 18.7K | 73,455,330 | D | ↗ |
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 100,000 | 0.75 | 74.8K | 73,430,330 | D | ↗ |
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 468,000 | 0.70 | 326.0K | 73,330,330 | D | ↗ |
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 268,105 | 0.73 | 194.6K | 72,862,330 | D | ↗ |
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 1,900 | 0.61 | 1.2K | 72,594,225 | D | ↗ |
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 1,032,218 | 0.61 | 627.7K | 72,592,325 | D | ↗ |
| 2025-03-01 | Weber Darin J. | Officer | A-Award | A | Employee stock option (right to buy) | 450,000 | 1.23 | 553.5K | 450,000 | D | ↗ |
| 2025-03-01 | Girolamo Todd C | Officer | A-Award | A | Employee stock option (right to buy) | 650,000 | 1.23 | 799.5K | 650,000 | D | ↗ |
| 2025-03-01 | Culleton Bruce | Director / Officer | A-Award | A | Employee stock option (right to buy) | 1,796,000 | 1.23 | 2.21M | 1,796,000 | D | ↗ |
| 2025-03-01 | Coulston James | Officer | A-Award | A | Employee stock option (right to buy) | 650,000 | 1.23 | 799.5K | 650,000 | D | ↗ |
| 2025-02-04 | Pereira Brian JG | Director | C-Conversion | D | Class B Ordinary Shares | 81,928 | 0.00 | — | 81,929 | D | ↗ |
| 2025-02-04 | Legorreta Pablo G. | Director / 10% Owner | J-Other | D | Class A Ordinary Shares | 532,535 | 0.00 | — | 22,617,909 | I | ↗ |
| 2024-09-19 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 16,412 | 2.50 | 41.0K | 103,480 | D | ↗ |
| 2024-09-13 | Culleton Bruce | Director / Officer | A-Award | A | Employee stock option (right to buy) | 500,000 | 1.69 | 845.0K | 500,000 | — | ↗ |
| 2024-09-03 | Fox Jennifer A. | Director | A-Award | A | Director stock option (right to buy) | 9,535 | 2.40 | 22.9K | 9,535 | — | ↗ |
| 2024-08-28 | Cowen Aaron | 10% Owner | — | — | Class A ordinary shares, par value $0.0001 per share | 0 | 0.00 | — | 11,428,937 | I | ↗ |
| 2024-07-31 | Girolamo Todd C | Officer | C-Conversion | A | Class A Ordinary Shares | 81,928 | 0.00 | — | 163,856 | — | ↗ |
| 2024-07-26 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 826 | 2.50 | 2.1K | 119,892 | — | ↗ |
| 2024-06-18 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 17,238 | 2.82 | 48.6K | 120,718 | — | ↗ |
| 2024-06-13 | Legorreta Pablo G. | Director / 10% Owner | P-Purchase | A | Class A Ordinary Shares | 22,617,909 | 2.42 | 54.74M | 22,617,909 | — | ↗ |
| 2024-06-11 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 8,264,462 | 2.42 | 20.00M | 71,560,107 | — | ↗ |
| 2024-05-30 | Sinha Uma | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | Pereira Brian JG | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | Lotvin Alan | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | Legorreta Pablo G. | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | Jimenez Santos Jose Ignacio | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | Fox Jennifer A. | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-30 | DOYLE WILLIAM F | Director | A-Award | A | Director stock option (right to buy) | 62,558 | 4.20 | 262.7K | 62,558 | — | ↗ |
| 2024-05-20 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 17,238 | 4.08 | 70.4K | 137,956 | — | ↗ |
| 2024-04-22 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 16,438 | 2.51 | 41.3K | 155,194 | — | ↗ |
| 2024-04-18 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 800 | 2.54 | 2.0K | 171,632 | — | ↗ |
| 2024-04-16 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 17,238 | 2.50 | 43.1K | 172,432 | — | ↗ |
| 2024-04-12 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 84,103 | 1.73 | 145.5K | 189,670 | — | ↗ |
| 2024-04-01 | Weber Darin J. | Officer | S-Sale | D | Class A Ordinary Shares | 300 | 1.69 | 507.00 | 273,773 | — | ↗ |
| 2024-04-01 | Ernst Ulrich Peter Alfred | Officer | A-Award | A | Employee stock option (right to buy) | 335,000 | 1.60 | 536.0K | 335,000 | — | ↗ |
| 2024-03-25 | Ernst Ulrich Peter Alfred | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-25 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 30,000 | 1.43 | 43.0K | 63,295,645 | — | ↗ |
| 2024-03-22 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 14,000 | 1.40 | 19.6K | 63,265,645 | — | ↗ |
| 2024-03-20 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 33,000 | 1.40 | 46.1K | 63,251,645 | — | ↗ |
| 2024-03-14 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 50,000 | 1.36 | 67.9K | 63,218,645 | — | ↗ |
| 2024-03-13 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | P-Purchase | A | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 50,000 | 1.50 | 75.1K | 63,168,645 | — | ↗ |
| 2024-03-01 | Weber Darin J. | Officer | A-Award | A | Employee stock option (right to buy) | 225,000 | 1.61 | 362.3K | 225,000 | — | ↗ |
| 2024-03-01 | Girolamo Todd C | Officer | A-Award | A | Employee stock option (right to buy) | 300,000 | 1.61 | 483.0K | 300,000 | — | ↗ |
| 2024-03-01 | Coulston James | Officer | A-Award | A | Employee stock option (right to buy) | 275,000 | 1.61 | 442.8K | 275,000 | — | ↗ |
| 2024-02-05 | Weber Darin J. | Officer | C-Conversion | A | Class A Ordinary Shares | 137,073 | 0.00 | — | 274,073 | — | ↗ |
| 2024-02-05 | Legorreta Pablo G. | Director / 10% Owner | J-Other | D | Class A Ordinary Shares | 748,952 | 0.00 | — | 0 | — | ↗ |
| 2024-02-05 | Girolamo Todd C | Officer | C-Conversion | A | Class A Ordinary Shares | 81,928 | 0.00 | — | 81,928 | — | ↗ |
| 2023-12-03 | Culleton Bruce | Director / Officer | A-Award | A | Employee stock option (right to buy) | 2,000,000 | 1.69 | 3.38M | 2,000,000 | — | ↗ |
| 2023-11-19 | Palihapitiya Chamath | — | S-Sale | D | Class A ordinary shares | 2,073,000 | 1.31 | 2.71M | 0 | — | ↗ |
| 2023-11-17 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 258,400 | 1.19 | 308.4K | 5,183,367 | — | ↗ |
| 2023-11-16 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 212,100 | 1.22 | 259.4K | 5,441,767 | — | ↗ |
| 2023-11-15 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 282,300 | 1.49 | 420.1K | 5,653,867 | — | ↗ |
| 2023-11-14 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 306,200 | 1.50 | 459.1K | 5,936,167 | — | ↗ |
| 2023-11-13 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 88,700 | 1.57 | 139.7K | 6,242,367 | — | ↗ |
| 2023-11-10 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 85,900 | 1.61 | 138.4K | 6,331,067 | — | ↗ |
| 2023-11-09 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 95,900 | 1.68 | 160.7K | 6,416,967 | — | ↗ |
| 2023-11-08 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 59,000 | 1.66 | 97.8K | 6,512,867 | — | ↗ |
| 2023-11-07 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 71,233 | 1.59 | 113.4K | 6,571,867 | — | ↗ |
| 2023-11-06 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 79,600 | 1.56 | 123.8K | 6,643,100 | — | ↗ |
| 2023-11-03 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 148,300 | 1.73 | 256.5K | 6,722,700 | — | ↗ |
| 2023-11-02 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 133,700 | 1.73 | 232.0K | 6,871,000 | — | ↗ |
| 2023-11-01 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 123,400 | 1.62 | 199.7K | 7,004,700 | — | ↗ |
| 2023-10-31 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 141,900 | 1.69 | 239.3K | 7,128,100 | — | ↗ |
| 2023-10-30 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 157,000 | 1.65 | 259.5K | 7,270,000 | — | ↗ |
| 2023-10-30 | Legorreta Pablo G. | Director / 10% Owner | C-Conversion | D | Common Units in ProKidney LP | 5,289,055 | 0.00 | — | 89,388,913 | — | ↗ |
| 2023-10-27 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 92,500 | 1.59 | 146.7K | 7,427,000 | — | ↗ |
| 2023-10-26 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 77,960 | 1.80 | 140.6K | 7,519,500 | — | ↗ |
| 2023-10-25 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 67,213 | 1.76 | 118.4K | 7,597,460 | — | ↗ |
| 2023-10-24 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 176,300 | 1.75 | 308.6K | 7,664,673 | — | ↗ |
| 2023-10-23 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 160,300 | 1.83 | 293.4K | 7,840,973 | — | ↗ |
| 2023-10-20 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 87,200 | 1.92 | 167.8K | 8,001,273 | — | ↗ |
| 2023-10-19 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 200,000 | 2.19 | 438.7K | 8,088,473 | — | ↗ |
| 2023-10-18 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 125,100 | 2.28 | 285.4K | 8,288,473 | — | ↗ |
| 2023-10-17 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 106,400 | 2.83 | 301.4K | 8,413,573 | — | ↗ |
| 2023-10-16 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 215,543 | 2.87 | 618.6K | 8,519,973 | — | ↗ |
| 2023-10-13 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 250,000 | 2.67 | 667.5K | 8,735,516 | — | ↗ |
| 2023-10-12 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 18,775 | 3.14 | 59.0K | 9,128,604 | — | ↗ |
| 2023-10-11 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 75,000 | 3.84 | 288.3K | 9,147,379 | — | ↗ |
| 2023-10-10 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 75,000 | 4.34 | 325.2K | 9,222,379 | — | ↗ |
| 2023-10-09 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 75,000 | 4.20 | 315.2K | 9,297,379 | — | ↗ |
| 2023-10-06 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 75,000 | 4.48 | 336.4K | 9,372,379 | — | ↗ |
| 2023-10-05 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 52,621 | 4.76 | 250.7K | 9,447,379 | — | ↗ |
| 2023-09-19 | Palihapitiya Chamath | 10% Owner | S-Sale | D | Class A ordinary shares | 1,700,000 | 5.47 | 9.30M | 2,073,000 | — | ↗ |
| 2023-08-25 | Weber Darin J. | Officer | C-Conversion | A | Class A Ordinary Shares | 137,000 | 0.00 | — | 137,000 | — | ↗ |
| 2023-08-01 | Culleton Bruce | Officer | A-Award | A | Employee stock option (right to buy) | 485,000 | 13.08 | 6.34M | 485,000 | — | ↗ |
| 2023-07-17 | Culleton Bruce | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-12 | Fox Jennifer A. | Director | A-Award | A | Director stock option (right to buy) | 46,632 | 10.92 | 509.2K | 46,632 | — | ↗ |
| 2023-06-29 | Sinha Uma | Director | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | Pereira Brian JG | Director | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | MARAGANORE JOHN | Director | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | Lotvin Alan | Director | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | Legorreta Pablo G. | Director / 10% Owner | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | Jimenez Santos Jose Ignacio | Director | A-Award | A | Director stock option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-06-29 | DOYLE WILLIAM F | Director | A-Award | A | Director Stock Option (right to buy) | 48,128 | 10.56 | 508.2K | 48,128 | — | ↗ |
| 2023-03-31 | Cowen Aaron | 10% Owner | J-Other | A | Class A ordinary shares | 857,500 | 0.00 | — | 4,050,675 | — | ↗ |
| 2023-01-16 | Weger Mary | Officer | A-Award | A | Employee stock option (right to buy) | 185,000 | 0.00 | — | 185,000 | — | ↗ |
| 2023-01-16 | Weber Darin J. | Officer | A-Award | A | Employee stock option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-16 | McKenzie Libbie Parker | Officer | A-Award | A | Employee stock option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-16 | Jain Deepak | Officer | A-Award | A | Employee stock option (right to buy) | 585,000 | 0.00 | — | 585,000 | — | ↗ |
| 2023-01-16 | Girolamo Todd C | Officer | A-Award | A | Employee stock option (right to buy) | 290,000 | 0.00 | — | 290,000 | — | ↗ |
| 2023-01-16 | Coulston James | Officer | A-Award | A | Employee stock option, right to buy | 290,000 | 0.00 | — | 290,000 | — | ↗ |
| 2023-01-16 | Bertram Timothy | Officer | A-Award | A | Employee stock option (right to buy) | 1,011,500 | 0.00 | — | 1,011,500 | — | ↗ |
| 2022-12-01 | Weger Mary | Officer | — | D | Common Units in ProKidney LP | 40,964 | 0.00 | — | — | — | ↗ |
| 2022-10-20 | Weber Darin J. | Officer | A-Award | A | Employee stock option (right to buy) | 418,076 | 0.00 | — | 418,076 | — | ↗ |
| 2022-10-20 | McKenzie Libbie Parker | Officer | A-Award | A | Employee stock option (right to buy) | 696,793 | 0.00 | — | 696,793 | — | ↗ |
| 2022-10-20 | Jain Deepak | Officer | A-Award | A | Employee stock option (right to buy) | 929,507 | 0.00 | — | 929,507 | — | ↗ |
| 2022-10-20 | Girolamo Todd C | Officer | A-Award | A | Employee stock option (right to buy) | 696,793 | 0.00 | — | 696,793 | — | ↗ |
| 2022-10-20 | Coulston James | Officer | A-Award | A | Employee stock option (right to buy) | 325,170 | 0.00 | — | 325,170 | — | ↗ |
| 2022-10-20 | Bertram Timothy | Officer | A-Award | A | Employee stock option (right to buy) | 3,639,607 | 0.00 | — | 3,639,607 | — | ↗ |
| 2022-09-20 | Fox Jennifer A. | Director | A-Award | A | Stock option (right to buy) | 129,370 | 9.73 | 1.26M | 129,370 | — | ↗ |
| 2022-09-06 | Cowen Aaron | 10% Owner | P-Purchase | A | Class A Ordinary Shares | 7,007 | 6.99 | 49.0K | 6,280,175 | — | ↗ |
| 2022-08-31 | Cowen Aaron | 10% Owner | P-Purchase | A | Class A Ordinary Shares | 2,100 | 8.94 | 18.8K | 6,273,168 | — | ↗ |
| 2022-08-30 | Cowen Aaron | 10% Owner | P-Purchase | A | Class A Ordinary Shares | 706 | 7.49 | 5.3K | 6,270,006 | — | ↗ |
| 2022-07-11 | Weber Darin J. | Officer | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Sinha Uma | Director | A-Award | A | Class A Ordinary Shares | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-07-11 | SCS Sponsor III LLC | — | M-Exempt | A | Class A ordinary shares | 6,220,000 | 0.00 | — | 6,860,000 | — | ↗ |
| 2022-07-11 | SC Master Holdings, LLC | 10% Owner | — | D | Class A ordinary shares | 0 | 0.00 | — | 13,273,000 | — | ↗ |
| 2022-07-11 | Pereira Brian JG | Director | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Palihapitiya Chamath | 10% Owner | J-Other | D | Class A ordinary shares | 3,087,000 | 0.00 | — | 16,273,000 | — | ↗ |
| 2022-07-11 | McKenzie Libbie Parker | Officer | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | MARAGANORE JOHN | Director | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Lotvin Alan | Director | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Legorreta Pablo G. | Director / 10% Owner | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Jimenez Santos Jose Ignacio | Director | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Jain Deepak | Officer | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Girolamo Todd C | Officer | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Fox Jennifer A. | Director | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | DOYLE WILLIAM F | Director | A-Award | A | Common Units in ProKidney LP | 1,514,326 | 0.00 | — | 1,514,326 | — | ↗ |
| 2022-07-11 | Cowen Aaron | 10% Owner | — | I | Class A ordinary shares, par value $0.0001 per share | 0 | 0.00 | — | 3,182,300 | — | ↗ |
| 2022-07-11 | Coulston James | Officer | — | D | No securities owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-11 | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | A-Award | A | Class B Ordinary Shares | 63,118,645 | 0.00 | — | 63,118,645 | — | ↗ |
| 2022-07-11 | Bertram Timothy | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Sinha Uma | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-16 | SCS Sponsor III LLC | Director / 10% Owner | D-Return | D | Class B ordinary shares | 75,000 | 0.00 | — | 6,220,000 | — | ↗ |
| 2021-07-02 | SCS Sponsor III LLC | Director / 10% Owner | A-Award | A | Class A ordinary shares | 640,000 | 10.00 | 6.40M | 640,000 | — | ↗ |
| 2021-06-29 | Semigran Marc | Director | — | D | Class B ordinary shares | 30,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-29 | SCS Sponsor III LLC | Director / 10% Owner | — | D | Class B ordinary shares | 6,295,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-29 | Ryans James | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-29 | Katz Shoney | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.1K
Shares Outstanding
127.57M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Bruce Culleton, M.D. Chief Executive Officer | 687.7K | — | — | 1.78M | 478.1K | 15.5K | 2.96M | 60.04% | ↗ |
| 2 | 2025 | Todd C. Girolamo Chief Legal Officer | 466.2K | — | — | 642.5K | 243.0K | 15.9K | 1.37M | 46.98% | ↗ |
| 3 | 2025 | James Coulston Chief Financial Officer | 465.9K | — | — | 642.5K | 243.0K | 15.9K | 1.37M | 46.99% | ↗ |
| 4 | 2024 | Todd C. Girolamo Chief Legal Officer | 425.0K | — | — | 625.0K | 195.1K | 15.8K | 1.26M | 49.57% | ↗ |
| 5 | 2024 | Bruce Culleton, M.D. Chief Executive Officer | 625.0K | — | — | — | 375.0K | 15.8K | 1.02M | 0.00% | ↗ |
| 6 | 2024 | James Coulston Chief Financial Officer | 420.0K | — | — | 323.8K | 192.8K | 13.5K | 950.1K | 34.08% | ↗ |
| 7 | 2023 | Bruce Culleton, M.D. Chief Executive Officer | 245.0K | — | — | 8.35M | 120.8K | 891.00 | 8.71M | 95.79% | ↗ |
| 8 | 2023 | Tim Bertram, Ph.D. Former Chief Executive Officer | 544.1K | — | — | 6.12M | 194.3K | 720.8K | 7.58M | 80.74% | ↗ |
| 9 | 2023 | Deepak Jain, Ph.D. Former Chief Operating Officer | 453.8K | — | — | 3.54M | 121.1K | 413.2K | 4.53M | 78.17% | ↗ |
| 10 | 2023 | Todd C. Girolamo Chief Legal Officer | 425.0K | — | — | 1.75M | 101.7K | 14.9K | 2.30M | 76.40% | ↗ |
| 11 | 2023 | James Coulston Chief Financial Officer | 420.0K | — | — | 1.75M | 100.5K | 12.7K | 2.29M | 76.68% | ↗ |
| 12 | 2022 | Tim Bertram, Ph.D. Chief Executive Officer | 600.0K | — | 16.96M | 28.20M | 344.3K | 26.1K | 46.13M | 97.90% | ↗ |
| 13 | 2022 | Tim Bertram, Ph.D. Former Chief Executive Officer | 600.0K | — | 16.96M | 28.20M | 344.3K | 26.1K | 46.13M | 97.90% | ↗ |
| 14 | 2022 | Deepak Jain, Ph.D. Former Chief Operating Officer | 485.4K | — | 5.02M | 6.97M | 268.3K | 14.9K | 12.76M | 93.98% | ↗ |
| 15 | 2022 | Deepak Jain, Ph.D. Chief Operating Officer | 485.4K | — | 5.02M | 6.97M | 268.3K | 14.9K | 12.76M | 93.98% | ↗ |
| 16 | 2022 | Todd C. Girolamo Chief Legal Officer | 325.7K | — | 2.41M | 5.23M | 136.8K | 137.7K | 8.24M | 92.71% | ↗ |
| 17 | 2021 | Tim Bertram, Ph.D. Chief Executive Officer | 489.3K | 360.0K | — | — | — | 24.5K | 873.8K | 0.00% | ↗ |
| 18 | 2021 | Deepak Jain, Ph.D. Chief Operating Officer | 401.7K | 216.0K | — | — | — | 14.5K | 632.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bruce Culleton | Chief Executive Officer & Director | 1M | — |
| Todd C. Girolamo | Chief Legal Officer & Secretary | 725.1K | male |
| James Coulston | Chief Financial Officer | 724.9K | male |
| Ulrich Ernst | EVice President of Science and Technology | 622.7K | — |
| Emily Butler | Senior Vice President of Biometric | — | — |
| Gregory Madison | Chief Commercial Officer | — | male |
| Darin J. Weber | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access | — | — |
| Joseph Stavas | SVP of Clinical Affairs | — | — |
| Nikhil L. Pereira-Kamath | Chief Business Officer | — | male |
| Richard Williams | Chief Information Officer | — | male |
| Carla Poulson | Chief People Officer | — | female |
| Anu Biswas | Senior Vice President of Manufacturing & Operations | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PROK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
